← SynDRA
PCO-371
SynDRA canonical compound SYN0038675 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | PTH1R |
|---|
| Indication | hypoparathyroidism |
|---|
| Disease area | endocrinology |
|---|
All known targets
Mechanisms of action (all sources)
Cross-references
Synonyms
- Pc-0371
- PCO371
- UNII-TE53TU0WSQ
- TE53TU0WSQ
- SCHEMBL17104864
- CHEMBL3976807
- US9428505, Compound 7
- BDBM64562
- PC-0371
- J3.591.565F
- 2,4-Imidazolidinedione, 1-(3,5-dimethyl-4-(2-((4-oxo-2-(4-(trifluoromethoxy)phenyl)-1,3,8-triazaspiro(4.5)dec-1-en-8-yl)sulfonyl)ethyl)phenyl)-5,5-dimethyl-
- RefChem:170503
- orb1307912
- C29H32F3N5O6S
- GTPL12788
- LDZJFVOUPUFOHX-UHFFFAOYSA-N
- GLXC-22283
- EX-A2839
- NPC37333
- MFCD31657324
- AKOS040742371
- SB19668
- compound 16c [PMID: 32022560]
- AC-31576
- DA-66512
- MS-30887
- SY235387
- HY-100856
- CS-0020524
- G16285
- T16442
Look up PCO-371 in the interactive SynDRA portal →